GTH(Delisted)
Genetron Holdings·NASDAQ
--
--(--)
GTH Profile
Genetron Holdings Limited
A leading precision oncology platform company in China that provides precision oncology medicine for the treatment of cancer
--
04/09/2018
06/19/2020
NASDAQ Stock Exchange
993
12-31
Depository Receipts (Ordinary Shares)
1-2/F, Building 11, Zone 1, No.8 Life Science Parkway, Changping District, Beijing, 102206, People’s Republic of China
Laboratory Development and Testing Services
Genetron Holdings Limited was incorporated in the Cayman Islands as an exempted limited liability company on 9 April 2018 under the Cayman Islands Companies Law (2018 Revision). It is a global cutting-edge cancer precision medicine company, focusing on the research and application of cancer genomics, providing products and services covering the whole cycle of cancer, such as early cancer screening, medication guidance, prognosis and monitoring, and drug research and development services. It is committed to applying innovative genomics technology to cancer-related diagnosis and treatment, and ultimately defeating cancer.
